Application of ibutilide in clincal atrial arrhythmia
10.3969/j.issn.1009-0126.2018.06.009
- VernacularTitle:伊布利特在房性心律失常中的临床应用
- Author:
Zerui FENG
1
;
Zhimin WANG
;
Baozeng CHEN
;
Fen WANG
;
Aizhi DONG
;
Zhaokai ZUO
;
Zegang SUN
;
Yun ZHANG
;
Lin MA
Author Information
1. 泰山医学院附属聊城市第二人民医院心内科
- Keywords:
atrial fibrillation;
atrial flutter;
amiodarone;
anti-arrhythmia agents
- From:Chinese Journal of Geriatric Heart Brain and Vessel Diseases
2018;20(6):593-595
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy and safety of ibutilide for AF and atrial flutter.Methods Thirty-two AF and atrial flutter patients with arrhythmia ≤3 months were randomly divided into ibutilide treatment group (n=17) and amiodarone treatment group (n=15).The patients in ibutilide treatment group were treated with 10 ml 5％ glucose injection containing 1 mg ibutilide,which was repeated after 10 min if it was ineffective and those in amiodarone treatment group were treated with 10 ml 5％ glucose injection containing 150 mg amiodarone,which was repeated after 10 min if it was ineffective.Results The total recovery rate of AF and atrial flutter was significantly higher in ibutilide treatment group than in amiodarone treatment group (64.7％ vs 40.0％,P＜0.05).The mean recovery time of AF and atrial flutter was significantly shorter in ibutilide treatment group than in amiodarone treatment group (29.28±12.57 min vs 70.59±16.83 min,P＜0.01).Conclusion Ibutilide can rapidly recover AF and atrial flutter with a high success rate and a reliable safety.The therapeutic effect of ibutilide is better than that of amiodarone for AF and atrial flutter.
